Canada markets open in 9 hours 28 minutes

Pangenomic Health Inc. (NARA.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.07000.0000 (0.00%)
At close: 10:11AM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 2.24M
Enterprise Value 3.18M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)5.38
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.11

Trading Information

Stock Price History

Beta (5Y Monthly) -1.38
52-Week Change 3-80.00%
S&P500 52-Week Change 334.78%
52 Week High 30.4000
52 Week Low 30.0250
50-Day Moving Average 30.0652
200-Day Moving Average 30.1070

Share Statistics

Avg Vol (3 month) 34.09k
Avg Vol (10 day) 32.26k
Shares Outstanding 532M
Implied Shares Outstanding 632M
Float 830.76M
% Held by Insiders 12.19%
% Held by Institutions 10.00%
Shares Short (Sept 13, 2024) 41.16k
Short Ratio (Sept 13, 2024) 40.3
Short % of Float (Sept 13, 2024) 4N/A
Short % of Shares Outstanding (Sept 13, 2024) 40.00%
Shares Short (prior month Aug 15, 2024) 41.5k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Mar 21, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-578.67%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -1.27M
Net Income Avi to Common (ttm)-3.71M
Diluted EPS (ttm)-2.9000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)13.9k
Total Cash Per Share (mrq)0
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.04
Book Value Per Share (mrq)-0.05

Cash Flow Statement

Operating Cash Flow (ttm)-499.01k
Levered Free Cash Flow (ttm)-208.04k